Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Tests | 1 | 2019 | 103 | 0.670 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 429 | 0.660 |
Why?
|
| Vaccines, DNA | 15 | 2003 | 305 | 0.650 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 326 | 0.630 |
Why?
|
| Complement System Proteins | 1 | 2019 | 795 | 0.550 |
Why?
|
| Immunoassay | 1 | 2019 | 752 | 0.540 |
Why?
|
| Allergens | 3 | 2016 | 1320 | 0.470 |
Why?
|
| Oncogene Proteins, Viral | 14 | 2003 | 362 | 0.420 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 51 | 0.390 |
Why?
|
| Pets | 1 | 2010 | 29 | 0.380 |
Why?
|
| Desensitization, Immunologic | 3 | 2013 | 483 | 0.360 |
Why?
|
| Viral Vaccines | 5 | 2022 | 636 | 0.360 |
Why?
|
| Immunity, Cellular | 2 | 2016 | 1607 | 0.360 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 619 | 0.330 |
Why?
|
| Cancer Vaccines | 11 | 2004 | 1023 | 0.300 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2134 | 0.300 |
Why?
|
| Asthma | 3 | 2016 | 6010 | 0.290 |
Why?
|
| Isoenzymes | 1 | 2011 | 1728 | 0.280 |
Why?
|
| Hypersensitivity | 2 | 2016 | 1102 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2016 | 4386 | 0.260 |
Why?
|
| Rhinitis | 1 | 2011 | 691 | 0.230 |
Why?
|
| Papillomaviridae | 6 | 2004 | 1119 | 0.210 |
Why?
|
| Sinusitis | 1 | 2011 | 923 | 0.200 |
Why?
|
| Monocytes | 1 | 2011 | 2596 | 0.200 |
Why?
|
| Sindbis Virus | 4 | 2002 | 37 | 0.200 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2019 | 37 | 0.180 |
Why?
|
| Papillomavirus E7 Proteins | 14 | 2003 | 123 | 0.180 |
Why?
|
| Cell Movement | 1 | 2011 | 5218 | 0.170 |
Why?
|
| Immunotherapy | 3 | 2010 | 4446 | 0.160 |
Why?
|
| Papillomavirus Vaccines | 2 | 2003 | 491 | 0.150 |
Why?
|
| Inflammation | 3 | 2016 | 10637 | 0.140 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2004 | 2020 | 0.120 |
Why?
|
| Chemokine CCL1 | 1 | 2014 | 18 | 0.120 |
Why?
|
| Skin Tests | 2 | 2013 | 613 | 0.120 |
Why?
|
| Th2 Cells | 2 | 2016 | 1061 | 0.120 |
Why?
|
| Drug Hypersensitivity | 2 | 2013 | 884 | 0.120 |
Why?
|
| Receptors, CCR8 | 1 | 2013 | 27 | 0.120 |
Why?
|
| Antigen Presentation | 7 | 2003 | 1284 | 0.110 |
Why?
|
| Chemokines, CC | 1 | 2013 | 291 | 0.110 |
Why?
|
| Organoplatinum Compounds | 1 | 2013 | 408 | 0.100 |
Why?
|
| Histocompatibility Antigens Class I | 6 | 2003 | 1366 | 0.100 |
Why?
|
| Vaccines, Synthetic | 3 | 2022 | 634 | 0.090 |
Why?
|
| Serine | 1 | 2014 | 826 | 0.090 |
Why?
|
| Cats | 1 | 2010 | 1000 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 349 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2001 | 404 | 0.080 |
Why?
|
| Carboplatin | 1 | 2011 | 801 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 13 | 2003 | 4479 | 0.080 |
Why?
|
| Viral Structural Proteins | 3 | 2002 | 103 | 0.070 |
Why?
|
| Dendritic Cells | 7 | 2003 | 2725 | 0.070 |
Why?
|
| Nasal Polyps | 1 | 2011 | 360 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 2 | 2001 | 1000 | 0.070 |
Why?
|
| Genes, MHC Class I | 2 | 2003 | 258 | 0.070 |
Why?
|
| Dogs | 1 | 2010 | 3912 | 0.070 |
Why?
|
| Vaccination | 5 | 2004 | 3279 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2002 | 1900 | 0.060 |
Why?
|
| Tumor Virus Infections | 3 | 2004 | 454 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 3773 | 0.060 |
Why?
|
| Immunotherapy, Active | 2 | 2001 | 60 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 16 | 2003 | 21833 | 0.060 |
Why?
|
| Neoplasms, Experimental | 3 | 2003 | 1276 | 0.060 |
Why?
|
| Antigens, Neoplasm | 2 | 2001 | 1988 | 0.060 |
Why?
|
| Papillomavirus Infections | 4 | 2004 | 1587 | 0.060 |
Why?
|
| Models, Biological | 1 | 2019 | 9584 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2002 | 1821 | 0.050 |
Why?
|
| Mardivirus | 1 | 2002 | 3 | 0.050 |
Why?
|
| Replicon | 1 | 2002 | 34 | 0.050 |
Why?
|
| RNA, Viral | 2 | 2001 | 2901 | 0.050 |
Why?
|
| Interferon-gamma | 4 | 2003 | 3207 | 0.050 |
Why?
|
| Centrosome | 1 | 2003 | 201 | 0.050 |
Why?
|
| Humans | 22 | 2022 | 744366 | 0.050 |
Why?
|
| ADP Ribose Transferases | 1 | 2001 | 90 | 0.050 |
Why?
|
| Exotoxins | 1 | 2001 | 119 | 0.050 |
Why?
|
| Animals | 20 | 2013 | 168768 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2001 | 1832 | 0.050 |
Why?
|
| Transfection | 5 | 2013 | 5895 | 0.040 |
Why?
|
| Tubulin | 1 | 2003 | 695 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2001 | 595 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2001 | 349 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 381 | 0.040 |
Why?
|
| Endosomes | 1 | 2001 | 519 | 0.040 |
Why?
|
| DNA | 2 | 2003 | 7294 | 0.040 |
Why?
|
| Lung Neoplasms | 8 | 2003 | 13104 | 0.040 |
Why?
|
| Antigens, Viral | 4 | 2002 | 1035 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2001 | 509 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 1081 | 0.040 |
Why?
|
| Mice | 17 | 2013 | 81201 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6313 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 9145 | 0.030 |
Why?
|
| Lysosomes | 1 | 2001 | 893 | 0.030 |
Why?
|
| Cell Line | 6 | 2013 | 16000 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 931 | 0.030 |
Why?
|
| Mucus | 1 | 2016 | 321 | 0.030 |
Why?
|
| Apoptosis | 4 | 2003 | 9724 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 9955 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.030 |
Why?
|
| Virus Replication | 1 | 2001 | 2535 | 0.030 |
Why?
|
| Biolistics | 2 | 2003 | 19 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2001 | 880 | 0.030 |
Why?
|
| Female | 19 | 2013 | 380193 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 934 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 379 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 13693 | 0.030 |
Why?
|
| Genetic Vectors | 4 | 2001 | 3424 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 2638 | 0.020 |
Why?
|
| Glycosylation | 1 | 2014 | 1128 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 13814 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2011 | 588 | 0.020 |
Why?
|
| Lymphocyte Depletion | 2 | 2003 | 608 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2013 | 607 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 18111 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2013 | 749 | 0.020 |
Why?
|
| Killer Cells, Natural | 3 | 2003 | 2133 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 2274 | 0.020 |
Why?
|
| Eosinophils | 1 | 2013 | 955 | 0.020 |
Why?
|
| Cricetinae | 2 | 2001 | 2475 | 0.020 |
Why?
|
| Cytokines | 2 | 2016 | 7323 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 3282 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 2804 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 2 | 2001 | 1146 | 0.020 |
Why?
|
| Neoplasms | 3 | 2002 | 21696 | 0.020 |
Why?
|
| Chimerin Proteins | 1 | 2003 | 7 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2001 | 7882 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 3848 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2001 | 3873 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 411 | 0.010 |
Why?
|
| Semliki forest virus | 1 | 2001 | 12 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5974 | 0.010 |
Why?
|
| Antigens, CD | 2 | 2003 | 4026 | 0.010 |
Why?
|
| Injections, Intradermal | 1 | 2001 | 117 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9384 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 758 | 0.010 |
Why?
|
| Calreticulin | 1 | 2001 | 98 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9312 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2013 | 3531 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 793 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7798 | 0.010 |
Why?
|
| Calcium | 1 | 2013 | 5755 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2001 | 5524 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 2001 | 286 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 928 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 385 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 560 | 0.010 |
Why?
|
| Antibodies, Viral | 2 | 2001 | 3177 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 644 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9688 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16367 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2000 | 552 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 667 | 0.010 |
Why?
|
| Electroporation | 1 | 2000 | 251 | 0.010 |
Why?
|
| Lung | 1 | 2016 | 9857 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2001 | 936 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 1420 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15078 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2001 | 1369 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2001 | 1147 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2003 | 14561 | 0.010 |
Why?
|
| Time Factors | 2 | 2013 | 40075 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 2086 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2173 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1225 | 0.010 |
Why?
|
| Biological Transport | 1 | 2001 | 2120 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1434 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 1758 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2308 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2001 | 743 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 1420 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2001 | 2421 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2001 | 1539 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2001 | 3689 | 0.010 |
Why?
|
| Spleen | 1 | 2001 | 2362 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6386 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2513 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 3749 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 214052 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3771 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 213390 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2000 | 4561 | 0.000 |
Why?
|
| Stem Cells | 1 | 2001 | 3567 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 56429 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 63107 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 72296 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2001 | 19233 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2013 | 77460 | 0.000 |
Why?
|
| Male | 2 | 2013 | 350115 | 0.000 |
Why?
|
| Aged | 1 | 2013 | 163288 | 0.000 |
Why?
|
Concepts
(187)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_